| Pharmacist participation in medical rounds reduces medication errors KK Scarsi, MA Fotis, GA Noskin American journal of health-system pharmacy 59 (21), 2089-2092, 2002 | 202 | 2002 |
| Comparative clinical pharmacokinetics and pharmacodynamics of HIV-1 integrase strand transfer inhibitors AT Podany, KK Scarsi, CV Fletcher Clinical pharmacokinetics 56 (1), 25-40, 2017 | 115 | 2017 |
| HIV-1 integrase inhibitors: a comparative review of efficacy and safety KK Scarsi, JP Havens, AT Podany, SN Avedissian, CV Fletcher Drugs 80 (16), 1649-1676, 2020 | 106 | 2020 |
| Point-of-care testing for infectious diseases: opportunities, barriers, and considerations in community pharmacy PO Gubbins, ME Klepser, AM Dering-Anderson, KA Bauer, KM Darin, ... Journal of the American Pharmacists Association 54 (2), 163-171, 2014 | 106 | 2014 |
| Ledipasvir plus sofosbuvir in pregnant women with hepatitis C virus infection: a phase 1 pharmacokinetic study CA Chappell, KK Scarsi, BJ Kirby, V Suri, A Gaggar, DL Bogen, IS Macio, ... The Lancet Microbe 1 (5), e200-e208, 2020 | 103 | 2020 |
| Minocycline treatment for HIV-associated cognitive impairment: results from a randomized trial N Sacktor, S Miyahara, L Deng, S Evans, G Schifitto, BA Cohen, R Paul, ... Neurology 77 (12), 1135-1142, 2011 | 102 | 2011 |
| Unintended pregnancies observed with combined use of the levonorgestrel contraceptive implant and efavirenz-based antiretroviral therapy: a three-arm pharmacokinetic evaluation … KK Scarsi, KM Darin, S Nakalema, DJ Back, P Byakika-Kibwika, LJ Else, ... Clinical Infectious Diseases 62 (6), 675-682, 2016 | 96 | 2016 |
| Pharmacist-provided rapid HIV testing in two community pharmacies KM Darin, ME Klepser, DE Klepser, SA Klepser, A Reeves, M Young, ... Journal of the American Pharmacists Association 55 (1), 81-88, 2015 | 81 | 2015 |
| Plasma and intracellular pharmacokinetics of tenofovir in patients switched from tenofovir disoproxil fumarate to tenofovir alafenamide AT Podany, SH Bares, J Havens, SR Dyavar, J O’Neill, S Lee, CV Fletcher, ... Aids 32 (6), 761-765, 2018 | 75 | 2018 |
| Impact of inactive empiric antimicrobial therapy on inpatient mortality and length of stay KK Scarsi, JM Feinglass, MH Scheetz, MJ Postelnick, MK Bolon, ... Antimicrobial agents and chemotherapy 50 (10), 3355-3360, 2006 | 64 | 2006 |
| Drug–drug interactions, effectiveness, and safety of hormonal contraceptives in women living with HIV KK Scarsi, KM Darin, CA Chappell, SM Nitz, M Lamorde Drug safety 39 (11), 1053-1072, 2016 | 56 | 2016 |
| Hepatotoxicity associated with long-versus short-course HIV-prophylactic nevirapine use: a systematic review and meta-analysis from the Research on Adverse Drug events And … JM McKoy, CL Bennett, MH Scheetz, V Differding, KL Chandler, KK Scarsi, ... Drug safety 32, 147-158, 2009 | 56 | 2009 |
| Acceptability and feasibility of a pharmacist-led HIV pre-exposure prophylaxis (PrEP) program in the Midwestern United States JP Havens, K Scarsi, H Sayles, DG Klepser, S Swindells, SH Bares Open forum infectious diseases 6 (10), 2019 | 55 | 2019 |
| The promise of improved adherence with long-acting antiretroviral therapy: what are the data? KK Scarsi, S Swindells Journal of the International Association of Providers of AIDS Care (JIAPAC …, 2021 | 51 | 2021 |
| Accumulation of protease mutations among patients failing second-line antiretroviral therapy and response to salvage therapy in Nigeria HE Rawizza, B Chaplin, ST Meloni, KM Darin, O Olaitan, KK Scarsi, ... PloS one 8 (9), e73582, 2013 | 50 | 2013 |
| Protein binding of lopinavir and ritonavir during 4 phases of pregnancy: implications for treatment guidelines KB Patterson, JB Dumond, HA Prince, AJ Jenkins, KK Scarsi, R Wang, ... JAIDS Journal of Acquired Immune Deficiency Syndromes 63 (1), 51-58, 2013 | 47 | 2013 |
| Antiretroviral pharmacokinetics in pregnant women EM Gilbert, KM Darin, KK Scarsi, MM McLaughlin Pharmacotherapy: The Journal of Human Pharmacology and Drug Therapy 35 (9 …, 2015 | 45 | 2015 |
| A phase 1 study of ledipasvir/sofosbuvir in pregnant women with hepatitis C virus CA Chappell, EE Krans, K Bunge, I Macio, D Bogen, KK Scarsi, LA Meyn, ... Conference on Retroviruses and Opportunistic Infections, 4-7, 2019 | 43 | 2019 |
| Efavirenz decreases etonogestrel exposure: a pharmacokinetic evaluation of implantable contraception with antiretroviral therapy CA Chappell, M Lamorde, S Nakalema, BA Chen, H Mackline, SA Riddler, ... AIDS 31 (14), 1965-1972, 2017 | 43 | 2017 |
| A new paradigm for antiretroviral delivery: long-acting cabotegravir and rilpivirine for the treatment and prevention of HIV SH Bares, KK Scarsi Current Opinion in HIV and AIDS 17 (1), 22-31, 2022 | 42 | 2022 |
